Perfusion Notes: [7]

FDA Advisory Committee Strongly Endorses Use of Trasylol® in CABG Surgery Patients

Bayer was glad to participate in today’s advisory committee meeting held by the Cardiovascular and Renal Drugs Division of the U.S. Food and Drug Administration (FDA). This session provided an open forum in which to discuss the complex scientific issues surrounding the risk/benefit profile of Trasylol® (aprotinin injection) in detail.

Methylene Blue to Treat Vasoplegia due to a Severe Protamine Reaction: A Case Report

This case report describes a 57-year-old woman who after cardiac bypass experienced a severe protamine reaction with profound hypotension, which was unresponsive to volume resuscitation and vasopressor therapy.

Early Experience of a Transcatheter Aortic Valve Program at a Veterans Affairs Facility

We retrospectively reviewed the records of all patients who underwent TAVR during the first year of our program at the Department of Cardiothoracic Surgery, Michael E. DeBakey Veterans Affairs Medical Center.